SureTrader
Interactive Brokers Advertisement
Home > Boards > Free Zone > User's Groups > Marijuana - Public Weed Stocks & Analysis (WEED)

$CARA Weekly - Cara Therapeutics, Inc., a clinical-stage

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DollarsOnPennies Member Profile
Member Level 
Followed By 261
Posts 428,378
Boards Moderated 3
Alias Born 05/14/10
160x600 placeholder
DollarsOnPennies Member Level  Friday, 10/06/17 02:39:40 AM
Re: None
Post # of 32520 
$CARA Weekly - Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Its lead product candidate includes intravenous CR845, which has completed Phase II clinical trials for the treatment acute postoperative pain in adult patients. The company is also developing Oral CR845 that has completed Phase I clinical trial for the treatment of moderate-to-severe acute and chronic pain; and CR701, which the company’s most advanced cannabinoid formula, is in preclinical trial for treating neuropathic and inflammatory pain. Cara Therapeutics, Inc. was founded in 2004 and is based in Shelton, Connecticut.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist